Tsukuba, Japan

Yuka Takagi

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: Yuka Takagi: Innovator in Pharmaceutical Adhesive Technologies

Introduction

Yuka Takagi is a prominent inventor based in Tsukuba, Japan. She has made significant contributions to the field of pharmaceutical adhesive technologies, holding a total of 9 patents. Her work focuses on developing innovative methods and products that enhance the delivery and effectiveness of medications.

Latest Patents

Among her latest patents is a method for suppressing the production of asenapine-N-oxide. This invention provides a patch that includes an adhesive layer on a backing, which comprises asenapine or a pharmaceutically acceptable salt thereof, an adhesive base, and at least one component selected from thiosulfates, sulfites, and pyrosulfites. Another notable patent is the asenapine-containing adhesive patch, which aims to offer excellent adhesiveness and handleability. This patch is designed to provide sustained medicinal effects while enhancing skin permeability and maintaining drug stability during storage.

Career Highlights

Yuka Takagi is currently employed at Hisamitsu Pharmaceutical Company, Inc., where she continues to innovate in the pharmaceutical sector. Her work has been instrumental in advancing adhesive technologies that improve patient outcomes.

Collaborations

Yuka has collaborated with notable colleagues, including Masaki Yukuhiro and Yasunari Michinaka, contributing to the development of her innovative products.

Conclusion

Yuka Takagi's contributions to pharmaceutical adhesive technologies exemplify her commitment to improving medication delivery systems. Her innovative patents reflect her expertise and dedication to enhancing patient care through effective pharmaceutical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…